Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. Drug (Description in trials) DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY Disease ID
130-hour ambulatory sampling of intestinal fluid----[1] 83
2Acetate[1] Acetate---[43] 1, 2, 6, 10, 13, 35, 40, 46, 49, 51, 60, 64, 67, 70, 71, 73, 75, 76, 78, 79, 81, 83, 85, 86, 88, 90, 96, 97, 113, 145, 156, 162, 171, 206, 222, 224, 225, 227, 235, 265, 288, 298, 299
3Betamethasone[1] Betamethasone[7] D00244 ,
D00972 ,
D01357 ,
D01402 ,
D01637 ,
D02032 ,
D02286 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[7] 2, 28, 46, 83, 90, 96, 235
4Cortef[1] Hydrocortisone cypionate[1] D00976 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
5Cortef (hydrocortisone)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
6Cortef 5 mg[1] Hydrocortisone cypionate[1] D00976 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
7Cosyntropin[1] Tetracosactide[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 83, 113, 145
8Dehydroepiandrosterone[1] Prasterone[1] D08409 [3] AR,
ESR1,
ESR2 💬		[12] Breast cancer, Chemical carcinogenesis - receptor activation, Endocrine and other factor-regulated calcium reabsorption, Endocrine resistance, Estrogen signaling pathway, GnRH secretion, Oocyte meiosis, Pathways in cancer, Prolactin signaling pathway, Prostate cancer, Proteoglycans in cancer, Thyroid hormone signaling pathway 💬[5] 49, 53, 83, 96, 113
9Depot tetracosactide[1] Tetracosactide[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83
10Diagnostic Test: Baseline blood tests----[1] 83
11Diagnostic Test: Cosyntropin stimulation test[1] Tetracosactide[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[1] 83
12Grapefruit[1] Grapefruit---[5] 6, 46, 50, 83, 97
13Grapefruit Juice[1] Grapefruit---[1] 83
14Hydrocortison 100 mg (Pfizer®) in 2 ml solvent----[1] 83
15Hydrocortisone[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[10] 6, 41, 46, 53, 75, 78, 81, 83, 97, 299
16Hydrocortisone 100mg/ml[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
17HYDROCORTISONE HYDROGEN SUCCINATE[3] Hydrocortisone,
Hydrocortisone succinate,
Hydrogen		[2] D00088 ,
D01442 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
18HYDROCORTISONE ROUSSEL[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
19HYDROCORTISONE SODIUM PHOSPHATE[2] Hydrocortisone,
Phosphate ion		[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 53, 81, 83
20HYDROCORTISONE SODIUM SUCCINATE[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 81, 83, 97
21Hydrocortisonum[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
22Hydrogen[1] Hydrogen---[7] 5, 6, 13, 17, 83, 97, 226
23Hydrokortison APL kapsel 2,5 mg----[1] 83
24Isocaloric Diet----[2] 2, 83
25Liquorice[1] Licorice[1] D04365 --[1] 83
26MabThera[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[22] 11, 13, 14, 19, 35, 43, 44, 46, 49, 50, 51, 52, 53, 61, 63, 64, 65, 83, 93, 162, 222, 271
27Mabthera Infusion[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[1] 83
28Medrone----[4] 46, 51, 83, 162
29Methylprednisolone[1] Methylprednisolone[6] D00407 ,
D00751 ,
D00979 ,
D05000 ,
D05001 ,
D05002 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[48] 2, 6, 11, 13, 14, 18, 19, 25, 26, 35, 38, 39, 40, 41, 42, 43, 45, 46, 49, 50, 51, 60, 62, 63, 64, 65, 66, 83, 84, 86, 93, 95, 96, 97, 127, 145, 162, 164, 211, 220, 222, 224, 271, 283, 284, 285, 296, 300
30Other: Blood test----[2] 83, 96
31Phosphate[1] Phosphate ion---[33] 2, 3, 6, 11, 12, 13, 15, 28, 36, 46, 49, 51, 53, 60, 62, 65, 70, 78, 81, 83, 90, 96, 97, 164, 235, 238, 256, 276, 283, 284, 285, 286, 299
32Rituximab[1] Rituximab[1] D02994 [1] MS4A1 💬[1] Hematopoietic cell lineage 💬[49] 6, 11, 13, 14, 17, 19, 35, 36, 41, 42, 43, 44, 45, 46, 49, 50, 51, 52, 53, 55, 56, 60, 61, 63, 64, 65, 66, 83, 84, 85, 86, 93, 94, 96, 97, 127, 162, 222, 229, 256, 271, 274, 283, 284, 285, 288, 296, 300, 331
33Solu-Cortef[2] Hydrocortisone cypionate,
Hydrocortisone succinate		[2] D00976 ,
D01442 		[1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[3] 6, 81, 83
34Solu-Cortef (hydrocortisone)[1] Hydrocortisone[1] D00088 [1] NR3C1 💬[1] Neuroactive ligand-receptor interaction 💬[1] 83
35Solu-Medrone----[3] 51, 83, 162
36Synacthen Depot[1] Tetracosactide[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[3] 83, 145, 222
37Tetracosactide[1] Tetracosactide[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[4] 83, 113, 145, 222
38Tetracosactide acetate[2] Acetate,
Tetracosactide		[1] D00284 [1] MC2R 💬[5] Aldosterone synthesis and secretion, Cortisol synthesis and secretion, Cushing syndrome, Neuroactive ligand-receptor interaction, cAMP signaling pathway 💬[2] 83, 145